IMB-1006

N/A

Report date: 2023/10/23 17:52:52

Base Information

Drug NameIMB-1006
Drug Alias NameIMB-1006
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsTardive Dyskinesia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesIMIDomics Inc
Inactive CompaniesN/A
Active IndicationsTardive Dyskinesia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A